Zoetis Inc. announced on 3 July 2020 that it is expanding its portfolio of health products and services for horses with the Stablelab hand-held, point-of-care diagnostic blood test that provides vets with critical information related to equine inflammation in 10 minutes.
The Stablelab hand-held reader detects and quantifies the biomarker Serum Amyloid A (SAA), a major, acute phase protein produced by the liver that rapidly and dramatically increases in response to inflammation. By measuring SAA, vets can assess the severity of an infection more quickly, often before clinical symptoms start and are able to monitor the horse’s response over the course of treatment.
“Zoetis is committed to providing vets and horse owners with the most effective health products to better predict, prevent, detect and treat equine disease,” said Zoetis vet Wendy Talbot. “The Stablelab test kit enables convenient, off-site testing for quick and accurate detection of a reliable indicator of infection in horses.
“Point-of-care testing is one of the fastest-growing areas of diagnostics and this test is rapidly becoming a standard of care in equine practice. SAA testing will help vets to quickly determine an appropriate course of intervention, positively impacting case outcomes.”
You can find out more about Stablelab at the website. To place an order please contact your Zoetis Account Manager or the Zoetis Technical Team on customersupportUK@zoetis.com or 0845 300 9084 choosing option 3.
Visit Horse Dialogue’s website for a wide range of client-focused information on disease risks, vaccination, equine health and wellbeing.
